Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

TRDATRDA
Showing 8 of 15 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in ENTRADA THERAPEUTICS INC

WELLINGTON MANAGEMENT GROUP LLP holds 954,419 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $7M as of 2026-Q2. The position was decreased (-7.8% shares). TRDA represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$7M

Current Shares

954,419

Total Value Change

-$9.4M

Total Shares Change

-74,950

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
954,419
-7.8%
$7M0.0%$7.36
0
2026-Q1
Decreased
1M
-0.9%
$13.1M0.0%$11.85
0
2025-Q4
Increased
1M
+9.5%
$10.7M0.0%$10.09
30
2025-Q3
Decreased
954,419
-10.0%
$5.5M0.0%$5.84
0
2025-Q2
Increased
1.1M
+0.7%
$7.1M0.0%$6.91
27
2025-Q1
Increased
1.1M
+2.1%
$9.5M0.0%$9.56
28
2024-Q4
Increased
1M
+0.2%
$17.8M0.0%$17.37
28
2024-Q3
Decreased
1M
-0.4%
$16.4M0.0%$16.45
0

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used